Phosphatase and tensin homolog (PTEN) is one of the best characterized tumour suppressors because it is mutated at a high frequency in a variety of human malignancies and inherited PTEN mutations cause cancer‐susceptibility conditions.1, 2, 3, 4. This evidence concerns the gene PTEN and cancer.